Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 6.25
-0.13 (-2.04%)
Feb 26, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 309.66 million as of February 26, 2026. Its market cap has increased by 172.34% in one year.
Market Cap
309.66M
Enterprise Value
284.81M
Revenue
10.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.25
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 309.66M, an increase of 152.48%. That is a compound annual growth rate of 21.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 309.66M | 22.22% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 384.20M |
| Ascelia Pharma AB | 378.70M |
| Lipum AB | 303.34M |
| Bio-Works Technologies AB | 294.30M |
| Mendus AB | 292.02M |
| Isofol Medical AB | 245.97M |
| Xintela AB | 242.88M |
| AlzeCure Pharma AB | 232.13M |